3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
Rituximab
9
ibrutinib
6
acalabrutinib
6
Cyclophosphamide
6
zanubrutinib
4
venetoclax
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Methotrexate
3
Magnetic Resonance Spectroscopy
3
Cytarabine
3
Cyclosporine
3
CT-P10
3
Bendamustine Hydrochloride
3
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Etoposide
2
Doxorubicin
2
Dexamethasone
2
Calcium Dobesilate
2
treosulfan
1
pirtobrutinib
1
palbociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
tipifarnib
×
30 days
×
Clear all
No trials found.